BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma Research

Sanyou Biopharmaceuticals Launches Cutting-Edge "oneClick+" Platform for Intelligent Antibody Design

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. officially announced the launch of the "Sanyou Innovative Intelligent Antibody Design oneClick+ Platform." ...

August 16, 2024 | News

Beckman Coulter Life Sciences and Illumina Launch Automated Solution for Faster, Comprehensive Oncology Genomic Profiling

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, in partnership with Illumina, a leader in DNA...

August 07, 2024 | News

Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors

Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...

August 07, 2024 | News

Leica Microsystems Launches AI-Powered Mateo FL for Advanced Cell Culture Research

Leica Microsystems, a leader in microscopy and scientific instrumentation, has released Mateo FL, an AI-powered digital fluorescence microscope for cell cu...

August 06, 2024 | News

Cresset and Enamine Expand Global Collaboration to Enhance Targeted Protein Degradation Research

Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Ena...

August 06, 2024 | News

Medicilon and Hengrui Pharma Forge Strategic Partnership to Accelerate Preclinical Drug Development

Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.&nb...

August 01, 2024 | News

NCCN Enhances Partnership with Medlive to Expand Oncology Guidelines Access in China

United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncol...

July 31, 2024 | News

Menarini Group Announces Positive Phase 3 Trial Results for Obicetrapib in Lowering LDL-C

-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically ...

July 30, 2024 | News

Akeso's Ivonescimab sBLA Accepted by NMPA for First-Line Treatment of PD-L1 Positive NSCLC

Akeso (9926.HK) is delighted to announce that the supplemental biologics license application (sBLA) for its independently developed, world's first-in-class...

July 30, 2024 | News

Pierre Fabre Laboratories Receives Positive CHMP Opinion for BRAFTOVI® + MEKTOVI® in Advanced NSCLC Treatment

Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval ...

July 29, 2024 | News

Sirnaomics Completes IND-Enabling Studies for siRNA Therapeutic STP125G Targeting ApoC3

Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”),...

July 24, 2024 | News

Pfizer Opens SGD$1 Billion Green Mark Gold-Certified API Manufacturing Facility in Singapore

Invests SGD$1 billion to produce small molecule APIs for oncology, pain, and antibiotic medicines The facility is Green Mark ‘Go...

July 23, 2024 | News

Duke-NUS Launches LIVE Ventures: S$20M to Commercialize Academic Research

Duke-NUS Medical School launched LIVE Ventures, a S$20 million incubation programme designed to catalyse the commercialisation of innovative acad...

July 22, 2024 | News

Sanyou Bio and Huadong Medicine Advance SYHD001 ADC Drug to Phase I Clinical Trials

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (hereinafter referred to as "Sanyou Bio") has recently announced a significant milestone in collaboration wi...

July 17, 2024 | News

Stay Connected